Li, Zhenhua http://orcid.org/0000-0001-9751-0864
Wang, Zhenzhen
Dinh, Phuong-Uyen C. http://orcid.org/0000-0002-8969-6256
Zhu, Dashuai http://orcid.org/0000-0002-4645-5786
Popowski, Kristen D. http://orcid.org/0000-0002-6341-2251
Lutz, Halle http://orcid.org/0000-0001-6364-7627
Hu, Shiqi
Lewis, Mark G.
Cook, Anthony
Andersen, Hanne
Greenhouse, Jack
Pessaint, Laurent
Lobo, Leonard J.
Cheng, Ke http://orcid.org/0000-0001-8053-7059
Funding for this research was provided by:
Foundation for the National Institutes of Health (HL123920, HL137093, HL144002, HL146153, HL147357, and HL149940)
American Heart Association (18TPA34230092 and 19EIA34660286)
Article History
Received: 23 June 2020
Accepted: 30 April 2021
First Online: 17 June 2021
Competing interests
: K.C. is a co-founder and equity holder of BreStem Therapeutics Inc. P.-U.C.D. reports compensation for consulting from BreStem Therapeutics Inc. The remaining authors declare no competing interests.
Free to read: This content has been made available to all.